CD79A and nasopharyngeal carcinoma: EBV-IgA seropositivity was shown by 212 family members of NPC patients (41.7%), compared to 64 individuals with chronic head and neck problems (32.7%) and 43 healthy individuals (16.4%) recruited from the blood bank (p<0.001).